Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reduction malarplasty using sliding setback osteotomy

B C Cho1, J H Lee, B S Baik

  • 1Department of Plastic and Reconstructive Surgery, Kyungpook National University Hospital, Taegu, Korea.

The Journal of Craniofacial Surgery
|August 7, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer': [ESMO Open. Volume 11, Issue 2, February 2026, 106057].

ESMO open·2026
Same author

Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer.

ESMO open·2026
Same author

Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study.

ESMO open·2025
Same author

BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter study.

ESMO open·2025
Same author

Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial.

Lung cancer (Amsterdam, Netherlands)·2025
Same journal

Further Considerations for Objective Facial Paralysis Assessment.

The Journal of craniofacial surgery·2026
Same journal

Microsurgical Anatomy and Surgical Relevance of the Internal Frontal Arteries: A Cadaveric Anatomic Study.

The Journal of craniofacial surgery·2026
Same journal

Pharyngeal Airway Changes Following Bimaxillary Orthognathic Surgery in Asian Patients.

The Journal of craniofacial surgery·2026
Same journal

Endoscopic Transcaruncular Approach for Early Anterior Ethmoidal Artery Cauterization in Large Olfactory Groove Meningioma Surgery: Intraoperative Video.

The Journal of craniofacial surgery·2026
Same journal

Clinical Manifestation of Congenital Unilateral Lower Lip Palsy: A Study of 111 Patients.

The Journal of craniofacial surgery·2026
Same journal

Racial and Regional Differences of the Cheek for Facial Feminization: A Systematic Review.

The Journal of craniofacial surgery·2026
See all related articles

This study presents a modified reduction malarplasty technique for prominent cheekbones, achieving satisfactory results and facial symmetry. The procedure preserves zygomatic blood supply, ensuring bone survival and minimizing cheek drooping.

Area of Science:

  • Plastic Surgery
  • Facial Aesthetic Surgery
  • Maxillofacial Surgery

Background:

  • Prominent malar complexes and mandibular angles can create a triangular, masculine facial appearance.
  • Surgical correction of prominent zygomas is frequently sought, particularly by Asian women.
  • Existing reduction malarplasty techniques, such as Baek's, involve under-positioning the osteotomized zygoma.

Purpose of the Study:

  • To modify Baek's reduction malarplasty by superoposteriorly sliding the osteotomized zygoma.
  • To evaluate the efficacy and safety of this modified technique in achieving facial contouring.
  • To assess patient satisfaction and aesthetic outcomes, focusing on symmetry and preservation of function.

Main Methods:

  • A modified reduction malarplasty technique was performed on ten patients with prominent zygomas.

Related Experiment Videos

  • The osteotomized zygoma was slid superoposteriorly, preserving its posterior soft tissue attachments and blood supply.
  • The masseteric origin was maintained to prevent significant cheek drooping post-operatively.

    • Main Results:

    • All ten patients reported high satisfaction with the aesthetic outcomes.
    • Excellent facial symmetry was achieved in all cases.
    • The modified procedure demonstrated precise malar reduction with good surgical exposure and zygomatic bone survival.

    Conclusions:

    • The modified superoposterior sliding reduction malarplasty is an effective technique for correcting prominent zygomas.
    • Preservation of the zygomatic blood supply ensures bone viability and minimizes complications.
    • This approach yields satisfactory aesthetic results, including improved facial symmetry and minimal cheek drooping.